Glycogen Storage Disease Type V
Information
- Disease name
- Glycogen Storage Disease Type V
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02432768 | Completed | Phase 2 | The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) | April 2015 | February 2019 |
| NCT03112889 | Completed | Phase 2 | Sodium Valproate for GSDV | January 2015 | April 5, 2017 |
| NCT03844022 | Completed | MRI in McArdle Disease (GSDV) | March 1, 2018 | February 1, 2021 | |
| NCT02635269 | Unknown status | N/A | Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy | January 2016 | December 2020 |
| NCT02919631 | Unknown status | Phase 2 | Triheptanoin in Mc Ardle | October 2016 | |
| NCT02385162 | Withdrawn | Biomarker for Glycogen Storage Diseases (BioGlycogen) | August 20, 2018 | February 28, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006012